Clinical Trials on Schizophrenia Relapse
Total 6266 results
-
Universidade Federal do Rio de JaneiroUnknown
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/STerminated
-
VA Office of Research and DevelopmentCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Autifony Therapeutics LimitedUniversity of ManchesterCompleted
-
Intra-Cellular Therapies, Inc.CompletedSchizophreniaUnited States
-
Centre Hospitalier St AnneInstitut National de la Santé Et de la Recherche Médicale, France; University...Unknown
-
Centre Hospitalier EsquirolCompleted
-
The Hong Kong Polytechnic UniversityCompletedSchizophrenia
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
GlaxoSmithKlineCompletedSchizophreniaUnited Kingdom
-
GlaxoSmithKlineCompleted
-
National Institute on Drug Abuse (NIDA)Withdrawn
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Hoffmann-La RocheCompletedSchizophreniaKorea, Republic of, United States, Hungary, Russian Federation, Argentina, Colombia, India, Australia, Finland, France, Mexico, Romania, Sweden, United Kingdom
-
Donald C. Goff, MDPfizerCompletedSchizophreniaUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
TakedaTerminatedSchizophreniaUnited States
-
Maosheng FangUnknown
-
Dong Wha Pharmaceutical Co. Ltd.The Catholic University of Korea; Konkuk University Hospital; Wonkwang University and other collaboratorsCompletedSchizophreniaKorea, Republic of
-
New York State Psychiatric InstituteMerck Sharp & Dohme LLC; Stanley Medical Research Institute; Sheba Medical CenterTerminated
-
H. Lundbeck A/SOtsuka Pharmaceutical Co., Ltd.Completed
-
Lundbeck Canada Inc.Otsuka Pharmaceutical Co., Ltd.Terminated
-
Intra-Cellular Therapies, Inc.CompletedSchizophreniaUnited States
-
Hospital Clinic of BarcelonaUniversity of BarcelonaCompleted
-
University of Sao PauloCompleted
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompleted
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, Italy, China, Japan, Russian Federation, Bulgaria, Czech Republic
-
Dr. Ram Manohar Lohia HospitalFogarty International Center of the National Institute of HealthCompletedSchizophrenia
-
University of Campania "Luigi Vanvitelli"University of Turin, Italy; University of Genova; University of BariCompleted
-
Veterans Medical Research FoundationNational Institute of Mental Health (NIMH)Completed
-
H. Lundbeck A/SCompletedSchizophreniaPhilippines, Hong Kong, Czech Republic, France, Indonesia, Poland, Spain, Thailand
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, China, Italy, Bulgaria, Russian Federation, Japan, Czech Republic
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.Completed
-
Taipei City HospitalCompleted
-
Posit Science CorporationNational Institute for Health Research, United KingdomCompletedSchizophreniaUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Completed
-
Northwell HealthNational Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University Hospital, MontpellierUniversity of Bristol; Université Montpellier; Ecole Polytechnique Fédérale de... and other collaboratorsUnknown
-
H. Lundbeck A/SOtsuka Pharmaceutical Co., Ltd.Withdrawn
-
Guangzhou Psychiatric HospitalUnknown
-
CoMentisAlpharmagen, Inc.SuspendedSchizophreniaUnited States